121 related articles for article (PubMed ID: 2873028)
21. High plasma cholecystokinin response following ingestion of test meal by patients with non-insulin dependent diabetes mellitus.
Nakano I; Funakoshi A; Shinozaki H; Miyazaki K; Ibayashi H; Tateishi K; Hamaoka T
Regul Pept; 1986 May; 14(3):229-36. PubMed ID: 3726174
[TBL] [Abstract][Full Text] [Related]
22. The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
Foot AB; Davidson K; Edge JA; Wass JA; Dunger DB
Clin Endocrinol (Oxf); 1990 Feb; 32(2):177-83. PubMed ID: 1971774
[TBL] [Abstract][Full Text] [Related]
23. Regulation of peripheral plasma somatostatin like immunoreactivity in type I diabetes: role of the degree of metabolic control.
Beylot M; Chayvialle JA; Rebattu B; Sautot G; Cohen R; Riou JP; Mornex R
Diabete Metab; 1986 Feb; 12(1):39-44. PubMed ID: 3516750
[TBL] [Abstract][Full Text] [Related]
24. Circadian variations of plasma somatostatin levels in healthy subjects.
Strazzulla G; Guazzelli R; Romano S; Matassi L; Cotrozzi G; Brocchi A
Chronobiologia; 1990; 17(3):219-25. PubMed ID: 1977563
[TBL] [Abstract][Full Text] [Related]
25. Extraction of somatostatin from human plasma on octadecylsilyl silica.
Vasquez B; Harris V; Unger RH
J Clin Endocrinol Metab; 1982 Oct; 55(4):807-9. PubMed ID: 6125526
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin-like immunoreactivity in man. Measurement in peripheral plasma.
Tronier B; Larsen UD
Diabete Metab; 1982 Mar; 8(1):35-40. PubMed ID: 6124467
[TBL] [Abstract][Full Text] [Related]
27. Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.
McIntosh CH; Bakich V; Bokenfohr K; DiScala-Guenot D; Kwok YN; Brown JC
Regul Pept; 1988 Jun; 21(3-4):205-18. PubMed ID: 2901134
[TBL] [Abstract][Full Text] [Related]
28. Effect of composition of mixed meals--low- versus high-carbohydrate content--on insulin, glucagon, and somatostatin release in healthy humans and in patients with NIDDM.
Gutniak M; Grill V; Efendić S
Diabetes Care; 1986; 9(3):244-9. PubMed ID: 2873976
[TBL] [Abstract][Full Text] [Related]
29. New alpha 2-adrenergic blocker (DG-5128) improves insulin secretion and in vivo glucose disposal in NIDDM patients.
Kashiwagi A; Harano Y; Suzuki M; Kojima H; Harada M; Nishio Y; Shigeta Y
Diabetes; 1986 Oct; 35(10):1085-9. PubMed ID: 2875910
[TBL] [Abstract][Full Text] [Related]
30. Effect of CCK-8 on basal and meal-stimulated somatostatin in the baboon.
Figlewicz DP; Woods SC; Porte D; Taborsky GJ
Peptides; 1986; 7(5):771-4. PubMed ID: 2879277
[TBL] [Abstract][Full Text] [Related]
31. Fluctuations in basal levels and effects of altered nutrition on plasma somatostatin.
Hansen BC; Vinik A; Jen KL; Schielke GP
Am J Physiol; 1982 Sep; 243(3):R289-95. PubMed ID: 6126125
[TBL] [Abstract][Full Text] [Related]
32. Effect of diet restriction on 24-hr urinary C-peptide excretion in non-insulin-dependent non-obese diabetic subjects.
Oshima Y
Tohoku J Exp Med; 1985 Mar; 145(3):329-33. PubMed ID: 2860737
[TBL] [Abstract][Full Text] [Related]
33. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
Wasada T; Dobbs RE; Harris V; Unger RH
Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
[TBL] [Abstract][Full Text] [Related]
34. Differential neural regulation of circulating somatostatin-14 and somatostatin-28 in conscious dogs.
Greenberg GR
Am J Physiol; 1993 May; 264(5 Pt 1):G902-9. PubMed ID: 8098911
[TBL] [Abstract][Full Text] [Related]
35. Opposing actions of glucagon and insulin on splanchnic d cell function.
Kawai K; Unger RH
J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
[TBL] [Abstract][Full Text] [Related]
36. Differential alterations of the circulating prosomatostatin-derived peptides during insulin-induced hypoglycemia in man.
Francis BH; Ensinck JW
J Clin Endocrinol Metab; 1987 Nov; 65(5):880-4. PubMed ID: 2889750
[TBL] [Abstract][Full Text] [Related]
37. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
[TBL] [Abstract][Full Text] [Related]
38. Hyperfunction of the entero-PP axis in non-insulin dependent diabetes mellitus.
Tsuda K; Seino Y; Mori K; Seino S; Takemura J; Kuzuya H; Imura H
Horm Metab Res; 1983 Dec; 15(12):581-5. PubMed ID: 6363240
[TBL] [Abstract][Full Text] [Related]
39. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
Kahn SE; Halban PA
Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
[TBL] [Abstract][Full Text] [Related]
40. Plasma somatostatin increases during hypoglycaemia in insulin-dependent patients with and without B-cell function.
Madsbad S; Hilsted J; Krarup T; Tronier B; Sestoft L
Clin Endocrinol (Oxf); 1983 Jul; 19(1):47-51. PubMed ID: 6137295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
